EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Non-Pharmacological Management of Idiopathic Pulmonary Fibrosis

Jon B Mullholand, Catherine E Grossman, Apostolos Perelas

Journal of Clinical Medicine · 17.02.2025 · 14 (4) · 1317

DOI: 10.3390/jcm14041317 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 17.02.2025. Verfasst von Jon B Mullholand und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Disease and Critical Care Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is a relatively common progressive fibrotic interstitial lung disease associated with significant morbidity and mortality. The available medications for IPF only slow down the disease process, with lung transplantation the only option for a cure. Non-pharmacological therapies are significant adjuncts that can improve symptom burden and quality of life with minimal or no side effects. Supplemental oxygen can improve exercise capacity and the sensation of dyspnea in a significant portion of patients with resting or exertional hypoxemia and has been supported by several professional societies. Pulmonary rehabilitation is a comprehensive program that includes education and therapeutic exercises to improve patient stamina and strength. It is one of the few interventions that have been shown to produce a meaningful increase in a patient’s exercise capacity, but its wide adoption is limited by availability, especially in rural areas. Sleep optimization with supplemental oxygen and positive airway pressure therapy should actively be investigated for all patients diagnosed with IPF. Although gastroesophageal reflux control with non-pharmacological means is still controversial as an intervention to reduce the rate of lung function decline, it can help control reflux symptoms and improve cough intensity. IPF patients should be educated on the importance of balanced nutrition and the potential benefits of screening for lung transplantation. Palliative medicine can help with symptom control and should be considered for all patients regardless severity, but especially in those in the later stages of disease.

Schlagwörter

Stichwörter der Autor:innen

GERDdietidiopathic pulmonary fibrosis (IPF)interstitial lung disease (ILD)lung cancerlung transplantpalliative carepulmonary rehabilitationsleepsupplemental oxygen

Autor:innen und Institutionen

  • Division of Pulmonary Disease and Critical Care Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.

Zitieren

APA

Mullholand, J. B., Grossman, C. E., & Perelas, A. (2025). Non-Pharmacological Management of Idiopathic Pulmonary Fibrosis. Journal of Clinical Medicine, 14(4), 1317. https://doi.org/10.3390/jcm14041317

Vancouver

Mullholand JB, Grossman CE, Perelas A. Non-Pharmacological Management of Idiopathic Pulmonary Fibrosis. Journal of Clinical Medicine. 2025;14(4):1317. doi:10.3390/jcm14041317

BibTeX
@article{Mullholand2025,
  author = {Mullholand, Jon B and Grossman, Catherine E and Perelas, Apostolos},
  title = {Non-Pharmacological Management of Idiopathic Pulmonary Fibrosis},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {4},
  pages = {1317},
  doi = {10.3390/jcm14041317}
}
Kostenlos starten →